These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21640152)

  • 21. The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: a comparison of published and unpublished studies.
    Kaczmarek MC; Duong UT; Ware RS; Lambert SB; Kelly HA
    Vaccine; 2013 Nov; 31(46):5359-65. PubMed ID: 24055353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010.
    Kelly H; Carcione D; Dowse G; Effler P
    Euro Surveill; 2010 Sep; 15(37):. PubMed ID: 20929647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
    Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age.
    Goodman MJ; Nordin JD; Harper P; Defor T; Zhou X
    Pediatrics; 2006 May; 117(5):e821-6. PubMed ID: 16651286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination.
    Talaat KR; Halsey NA; Cox AB; Coles CL; Durbin AP; Ramakrishnan A; Bream JH
    Influenza Other Respir Viruses; 2018 Mar; 12(2):202-210. PubMed ID: 28991404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children.
    Li-Kim-Moy J; Yin JK; Rashid H; Khandaker G; King C; Wood N; Macartney KK; Jones C; Booy R
    Euro Surveill; 2015 Jun; 20(24):. PubMed ID: 26111238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
    Jacoby P; Glover C; Damon C; Fathima P; Pillsbury A; Durrheim D; Gold MS; Leeb A; Snelling T
    BMJ Open; 2020 Mar; 10(2):e031851. PubMed ID: 32122906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB; Ambrose CS; Yi T
    Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Australian health authorities' response criticised after adverse events related to influenza vaccination in children.
    Sweet M
    BMJ; 2010 Aug; 341():c4470. PubMed ID: 20713588
    [No Abstract]   [Full Text] [Related]  

  • 31. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
    Zhu W; Higgs BW; Morehouse C; Streicher K; Ambrose CS; Woo J; Kemble GW; Jallal B; Yao Y
    Vaccine; 2010 Apr; 28(16):2865-76. PubMed ID: 20153794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events associated with 2010 CSL and other inactivated influenza vaccines.
    Kelly HA; Skowronski DM; De Serres G; Effler PV
    Med J Aust; 2011 Sep; 195(6):318-20. PubMed ID: 21929484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
    Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
    Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia.
    Wood N; Sheppeard V; Cashman P; Palasanthiran P; Casacelli M; Cannings K; McIntyre P
    Pediatr Infect Dis J; 2012 Feb; 31(2):199-202. PubMed ID: 22094632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.